---
title: "Theriva Biologics (TOVX.US) — 财务报表"
type: "Symbol"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/quote/TOVX.US/norm.md"
symbol: "TOVX.US"
name: "Theriva Biologics"
parent: "https://longbridge.com/zh-CN/quote/TOVX.US.md"
datetime: "2026-05-21T23:23:39.712Z"
locales:
  - [en](https://longbridge.com/en/quote/TOVX.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/TOVX.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/TOVX.US/norm.md)
---

# Theriva Biologics (TOVX.US) — 财务报表

## 利润表 (USD)

| 指标 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 每股收益 | -0.0498 | -0.1198 | -0.4507 | -1.93 | -1.55 |
| ROE | -53.12% | -126.79% | -200.96% | -399.94% | -100.08% |
| 营业收入 | 300000.00 | - | - | - | - |
| 净利润 | -2.04M | -3.51M | -4.36M | -13.06M | -4.32M |
| 营业利润 | -2.13M | -2.84M | -3.81M | -13.13M | -4.42M |
| 毛利率 | 100.00% | - | - | - | - |
| 净利率 | -681.33% | - | - | - | - |
| 利润含金量 | - | - | - | - | - |

## 资产负债表 (USD)

| 指标 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 资产与负债 | 38.25M | 38.24M | 30.84M | 35.83M | 32.16M |
| 权益乘数 | 2.48 | 2.49 | 4.58 | 3.37 | 2.08 |
| 每股净资产 | 0.3355 | 0.4310 | 0.6539 | 1.17 | 5.57 |
| 资产周转率 | 0.0085 | - | - | - | - |
| 现金及短投 | 14.43M | 13.06M | 7.53M | 12.12M | 10.01M |
| 存货与应收 | - | - | - | - | - |
| 长期投资 | 2.14M | 1.02M | 1.19M | 1.33M | 1.42M |
| 净债务 | -10.74M | -10.43M | -4.77M | -9.23M | -7.16M |

## 现金流量表 (USD)

| 指标 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 经营现金流 | -2.46M | -2.88M | -4.32M | -4.71M | -4.76M |
| 投资现金流 | - | 0.0000 | -19000.00 | -16000.00 | - |
| 融资现金流 | 3.87M | 8.46M | -148000.00 | 6.81M | 3.07M |
| 自由现金流 | 1.23M | -4.55M | -3.29M | -3.99M | 119375.00 |
| 现金流充裕率 | -5012.24% | -288200.00% | -20566.67% | -17451.85% | -8492.86% |
| 举债与偿债 | - | 15000.00 | 34000.00 | 57000.00 | 1.40M |
| 资本支出 | - | 0.0000 | -19000.00 | -16000.00 | - |